bromperidol has been researched along with flunitrazepam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukori, H; Hayashi, K; Inoue, Y; Kaneko, S; Kondo, T; Mihara, K; Otani, K; Suzuki, A; Tokinaga, N; Yasui, N | 1 |
| Abe, T; Kajii, E; Kato, S; Konno, T; Matsumoto, M; Tamba, K | 1 |
1 trial(s) available for bromperidol and flunitrazepam
| Article | Year |
|---|---|
Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite.
Topics: Adolescent; Adult; Aged; Aging; Anti-Anxiety Agents; Antipsychotic Agents; Biotransformation; Cytochrome P-450 CYP2D6; Female; Flunitrazepam; Genotype; Half-Life; Haloperidol; Humans; Male; Middle Aged; Oxidation-Reduction; Schizophrenia; Sex Characteristics; Smoking | 1998 |
1 other study(ies) available for bromperidol and flunitrazepam
| Article | Year |
|---|---|
Two cases of deep vein thrombosis associated with antipsychotic drug use.
Topics: Aged; Antipsychotic Agents; Chlorpromazine; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Overdose; Drug Therapy, Combination; Female; Flunitrazepam; Haloperidol; Humans; Middle Aged; Pulmonary Embolism; Risk; Schizophrenia; Venous Thrombosis | 2004 |